Iso-Oncotic Albumin Mitigates Brain and Kidney Injury in Experimental Focal Ischemic Stroke

Background: There is widespread debate regarding the use of albumin in ischemic stroke. We tested the hypothesis that an iso-oncotic solution of albumin (5%), administered earlier after acute ischemic stroke (3 h), could provide neuroprotection without causing kidney damage, compared to a hyper-onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Renata de S., Martins, Gloria, Oliveira, Milena V., Rocha, Nazareth N., Cruz, Fernanda F., Antunes, Mariana A., Abreu, Soraia C., Silva, Adriana L., Takiya, Christina, Pimentel-Coelho, Pedro M., Robba, Chiara, Mendez-Otero, Rosália, Pelosi, Paolo, Rocco, Patricia R. M., Silva, Pedro L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494813/
https://www.ncbi.nlm.nih.gov/pubmed/33013661
http://dx.doi.org/10.3389/fneur.2020.01001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494813/
https://www.ncbi.nlm.nih.gov/pubmed/33013661
http://dx.doi.org/10.3389/fneur.2020.01001

Ejemplares similares